⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL619548 | 1.00 | — | — | |
| SCHEMBL554471 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL352613 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL16333974 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL15573075 | 0.98 | — | — | |
| Oxalic Acid SCHEMBL351294 | 0.90 | SLC6A2 (0.36) | — | |
| Oxalic Acid SCHEMBL352319 | 0.90 | SLC6A2 (0.36) | — | |
| SCHEMBL352271 | 0.87 | MEN1 (0.38) | — | |
| SCHEMBL2794448 | 0.86 | — | — | |
| SCHEMBL16932248 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12456587-B2 | Solid electrolytic capacitor including electrolytic solution containing acid and amine, and method for manufacturing same | RUBYCON CORPORATION (JP) | 2025-10-28 | — | — | US | claimed |
| WO-2025076126-A1 | AGENTS THAT BIND NUCLEIC ACIDS ENCODING ELAVL3 CRYPTIC EXONS, PHARMACEUTICAL COMPOSITIONS, AND USES IN MANAGING NEUROLOGICAL DISEASES | EMORY UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| CN-118726541-B | Oligonucleotide fluorescent probe and method for detecting environmental DNA by using same | 青岛聚点儿科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-118685494-B | Nucleic acid probe and method for detecting DNA using the same | 青岛聚点儿科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119269664-A | Method for detecting genotoxic impurities in viloxazine hydrochloride | 苏州恩华生物医药科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-118726541-A | Oligonucleotide fluorescent probe and method for detecting environmental DNA by using same | 青岛聚点儿科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118685494-A | Nucleic acid probe and method for detecting DNA using the same | 青岛聚点儿科技有限公司 | 2024-09-24 | — | — | CN | claimed |
| US-20240279660-A1 | Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors | UNIV EMORY (US) | 2024-08-22 | — | — | US | claimed |
| CN-117720703-B | Comb-type polyurethane hyperdispersant and preparation method and application thereof | 珠海市金团化学品有限公司 | 2024-05-17 | — | — | CN | claimed |
| US-20240150326-A1 | CARBOXAMIDE COMPOUNDS AND USES THEREOF | INCYTE CORPORATION | 2024-05-09 | — | — | US | claimed |
| WO-2011114275-A1 | SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES | UNIVERSITY OF BASEL (CH) | 2011-09-22 | — | — | WO | claimed |
| US-7939534-B2 | e.g. (2-{[2-(3-fluorophenyl)ethyl]amino}-6-piperidyl(3-pyridyl))-N-(3-pyridylmethyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, chronic obstructive pulmonary disease, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction | CYTOKINETICS, INC. (US) | 2011-05-10 | — | — | US | claimed |
| US-20080139575-A1 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INC. | 2008-06-12 | — | — | US | claimed |
| WO-2008016643-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INCORPORATED (US) | 2008-02-07 | — | — | WO | claimed |
| US-20070259849-A1 | Azine-Carboxamides as Anti-Cancer Agents | ASTRAZENECA AB (SE) | 2007-11-08 | — | — | US | claimed |
| CN-101023063-A | Azine-carboxamides as anti-cancer agents | ASTRAZENECA AB (SE) | 2007-08-22 | — | — | CN | claimed |
| US-6846827-B1 | Pyrimidine derivatives | ASTRAZENECA AB (SE) | 2005-01-25 | — | — | US | claimed |
| EP-1226126-B1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-01-05 | — | — | EP | claimed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | claimed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | claimed |